1. Ureteral metastasis from locally invasive, castrate-resistant prostate cancer: a case report
- Author
-
Inger L. Rosner, Zachary C Janatpour, Santosh Shanmuga, and Edwin Gandia
- Subjects
medicine.medical_specialty ,Urology ,Castrate-resistant prostate cancer ,urologic and male genital diseases ,Nephroureterectomy ,Metastasis ,Lesion ,Androgen deprivation therapy ,Metastatic prostate cancer ,Prostate cancer ,Biopsy ,Medicine ,Ureteroscopy ,Hydronephrosis ,medicine.diagnostic_test ,business.industry ,Ureteral metastasis ,medicine.disease ,Diseases of the genitourinary system. Urology ,Oncology ,RC870-923 ,medicine.symptom ,business - Abstract
Within the text we describe a 66-year-old male with a history of prostate cancer (PCa), incidentally found to have left-sided hydronephrosis and a left ureteral lesion. Ureteroscopy was employed to visualize the lesion, a biopsy was taken, and a double J stent was placed. The lesion was of prostatic origin and the patient was subsequently started on androgen deprivation therapy (ADT). 6 months following the procedure, the patient's PSA had decreased and his hydronephrosis had resolved. We are the first to report treating a ureteral metastasis from PCa and its associated hydronephrosis solely with ADT and double J stenting, respectively.
- Published
- 2021